SlideShare a Scribd company logo
1 of 8
Download to read offline
Advocacy Groups:
Enhancing
Relationships and
Patient Recruitment
Info@ISRreports.com 		
				
			
©2013 Industry Standard Research www.ISRreports.com
PREVIEW
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 2
act with confidence
Report Overview
This report provides qualitative insight on advocacy groups’ relationships with the
pharmaceutical industry. The report explores their current philosophies toward
clinical trials, provides recommendations and best practices for encouraging patient
participation in trials, and identifies opportunities to partner (or build on existing
partnerships) with the industry.
What you will learn in this report
•	 The type of relationships advocacy groups desire with industry, including: involvement in clinical
trial design, collaboration on patient recruitment, and role in connecting patients to industry
•	 Advocacy groups’ concerns with encouraging clinical trials, including: the need to remain
neutral, patient education, and trial burden on patients
•	 Recommendations and best practices for delivering messages to patients and families about
clinical trials
How you can use this report:
•	 Uncover proven strategies to more effectively enroll patients in your rare disease/difficult-to-
recruit trials
•	 Learn to optimize communication strategies to ensure an “all inclusive” approach to
relationship management considers all key players (advocacy groups, patients, caregivers,
and investigators)
•	 Develop strategies to anticipate, discuss, and mitigate advocacy group concerns and hesitations
1. Relationships with Pharma
•	 Clinical Trial Design
•	 Patient-Industry Relationship
•	 Opportunities for Industry in Trial Design
Process
2. Clinical Trial Focus
•	 Clinical Trial Focus Spectrum
•	 Concerns with Encouraging Clinical Trials
•	 Website Focus on Clinical Trials
3. Clinical Trial Recruitment Practices
•	 Clinical Trials 101 – Back to the Basics
•	 Patient Registry
•	 Recruitment Best Practices
•	 Managing Relationships
4. Patient Advocacy Groups’ Requests of
Pharma
•	 Low Trial Focus Advocacy Groups
•	 High Trial Focus Advocacy Groups
5. Patient Advocacy Group Profiles
Major Sections
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 3
act with confidence
Methodology
In ISR’s qualitative analysis, ISR conducted 40-minute telephone interviews with senior decision-makers
at 10 US-based patient advocacy groups. The individuals interviewed hold a variety of roles within their
organizations, but all are in a position to speak to their organization’s philosophy on clinical trials, as well as
their organization’s broader relationships with the pharmaceutical industry.
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 4
act with confidence
Table of Contents
Full table of contents and additional sample pages available in the full preview,
free on our website:
http://www.isrreports.com/product/advocacy-groups-enhancing-relation-
ships-and-patient-recruitment/
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 5
act with confidence
www.isrreports.com	
  ©2013|	
  EDC-­‐ePRO	
  Market	
  Trends	
  and	
  Service	
  Provider	
  Performance	
  	
  	
  	
  	
  	
  	
  	
  26	
  
5%	
  
5%	
  
4%	
  
5%	
  
6%	
  
20%	
  
14%	
  
11%	
  
6%	
  
11%	
  
50%	
  
43%	
  
39%	
  
40%	
  
31%	
  
25%	
  
38%	
  
46%	
  
49%	
  
52%	
  
0%	
   20%	
   40%	
   60%	
   80%	
   100%	
  
Integra[on	
  capabili[es	
  with	
  other	
  
applica[ons	
  (ePRO,	
  IVR)	
  
Technical	
  support	
  from	
  the	
  vendor	
  
The	
  process	
  for	
  dealing	
  with	
  queries	
  
Speed	
  of	
  the	
  applica[ons,	
  how	
  fast	
  the	
  
pages	
  load	
  
Human-­‐machine	
  interface	
  (how	
  intui[ve	
  
the	
  soeware	
  is	
  to	
  operate)	
  
No	
  impact	
   Slight	
  impact	
   Moderate	
  impact	
   High	
  impact	
  
EDC Operational Improvements
Most impactful EDC product attributes for trial success
“For each of the EDC product attributes below, please indicate how much impact each
has on your ability to successfully run a clinical trial that uses an EDC application.”
(Base	
  =	
  100)	
  
Of	
  the	
  list	
  of	
  attributes	
  provided,	
  respondents	
  indicate	
  that	
  “technical	
  support”	
  and	
  “integration	
  
capabilities”	
  had	
  less	
  of	
  an	
  impact	
  on	
  running	
  clinical	
  trial	
  when	
  compared	
  to	
  the	
  software	
  
performance.	
  
© 2013 Industry Standard Research
Sample Page
Introduction
As ISR’s research has revealed time and again, patient recruitment is one of the
most difficult and time-consuming aspects of conducting a clinical trial. Though
the biopharmaceutical industry utilizes a wide range of recruiting techniques, one
that ISR believes has not been fully (or even adequately) leveraged is partnering
with patient advocacy groups to encourage trial participation.
Patient advocacy groups are spread across the spectrum regarding how
involved they are with clinical trial recruitment. All respondents posit that
clinical trials are the way to move forward but many have yet to delve into
playing a role in the recruitment process. There are various reasons why an
organization may not have fully developed this offering so industry will have
to tailor its approaches to individual advocacy organizations. The bright
side is that advocacy groups already playing in this space are searching for
continued and more involved partnering opportunities and organizations
without processes in place for patient education and recruitment are open
to discussing partnering options with industry.
This report sheds light on advocacy groups’ relationships with pharma,
current philosophies toward clinical trials, best practices for encouraging
patient participation in trials, and opportunities to partner (or build on
existing partnerships) with pharma.
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 6
act with confidence
Sample Page
Clinical Trial Recruiting Practices
act with confidence
www.ISRreports.com ©2013 | Advocacy Groups: Enhancing Relationships and Patient Recruitment 24
Best Practices
Advocacy organizations have developed some best practices and some unique ideas
for clinical trial education and recruitment� These practices will be detailed here as
organizations can learn from successful strategies of other advocacy groups and
industry can learn where it can lend a hand to support these initiatives�
Delivery is Key
Respondents shared several best practices in terms of delivering messages to patients
and families about clinical trials�
Consistent Language
Consistency in language is critical� When messaging about key facts about a clinical
trial, try to use the same wording as is used in other information about the trial
from the sponsor company or CRO� This will help the patient to form a coherent
understanding� Talk to PIs to understand how they talk about the trial with patients so
a consistent message can be relayed to the patient community�
Repetition
Repeat� Repeat� Repeat� The messages of education and encouragement to
participate in clinical trials have to be reinforced� One mention in a magazine article
is not going to get the job done� Patients need to be educated on what trials are and
need to be reminded about what trials are available� The National Multiple Sclerosis
Society, for example, has found that interest is generated when a news bulletin about a
study is first posted on its home page� If requested, the Society may or may not repost
a trial on the home page every few months to garner renewed interest�
Consistent
Language
Repetition
Audience
Understanding
Impactful
Message
©industry standard Research
This is an enterprise-wide license and this file is not to be distributed beyond the terms of this agreement. For information on the license holder, please contact ISR (info@ISRreports.com).
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 7
act with confidence
Sample Page
Full table of contents and additional sample pages available in the full preview,
free on our website:
http://www.isrreports.com/product/advocacy-groups-enhancing-relation-
ships-and-patient-recruitment/
www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 8
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma
and pharma services industries.  With over a decade of experience in the industry, ISR delivers an un-
matched level of domain expertise. 
 
For more information about our off-the-shelf intelligence and custom research offerings, please visit
our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
About Industry Standard Research
Pricing and ordering options are available on our website:
http://www.isrreports.com/product/advocacy-groups-enhancing-relation-
ships-and-patient-recruitment/

More Related Content

What's hot

Medical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryMedical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryBest Practices, LLC
 
CROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient RecruitmentCROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient RecruitmentJohn Reites
 
Service Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review Article
Service Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review ArticleService Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review Article
Service Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review ArticleYogeshIJTSRD
 
Medical Affairs Consortium
Medical Affairs Consortium Medical Affairs Consortium
Medical Affairs Consortium Best Practices
 
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)Mosio
 
Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5Greg Bauer
 
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...Avella Specialty Pharmacy
 
AMCP Keynote Presentation from Avella Specialty Pharmacy
AMCP Keynote Presentation from Avella Specialty PharmacyAMCP Keynote Presentation from Avella Specialty Pharmacy
AMCP Keynote Presentation from Avella Specialty PharmacyAvella Specialty Pharmacy
 
IMS Health Clinical Trial Optimization Solutions
IMS Health Clinical Trial Optimization SolutionsIMS Health Clinical Trial Optimization Solutions
IMS Health Clinical Trial Optimization SolutionsQuintilesIMS
 
Benchmarking surgical systems 2015-30: application of indicators from The Lan...
Benchmarking surgical systems 2015-30: application of indicators from The Lan...Benchmarking surgical systems 2015-30: application of indicators from The Lan...
Benchmarking surgical systems 2015-30: application of indicators from The Lan...Jonathan Meadows, DO, MS, MPH, CPH
 
2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy
2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy
2014 Armada Presentation - Specialty Pharmacy at Retail PharmacyAvella Specialty Pharmacy
 
Presentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchPresentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchklaffy
 
Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7The Avoca Group
 
Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Lynn Okamoto
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...TransCelerate
 
Avoca Investigative Site Survey Programs
Avoca Investigative Site Survey ProgramsAvoca Investigative Site Survey Programs
Avoca Investigative Site Survey ProgramsThe Avoca Group
 
Benchmarking Professional Medical Education Excellence Structures
Benchmarking Professional Medical Education Excellence StructuresBenchmarking Professional Medical Education Excellence Structures
Benchmarking Professional Medical Education Excellence StructuresBest Practices
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...Todd Berner MD
 

What's hot (20)

Medical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryMedical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report Summary
 
CROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient RecruitmentCROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient Recruitment
 
Service Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review Article
Service Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review ArticleService Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review Article
Service Marketing Mix 7Ps and Patient Satisfaction in Clinics A Review Article
 
Medical Affairs Consortium
Medical Affairs Consortium Medical Affairs Consortium
Medical Affairs Consortium
 
Medical Affairs Excellence Services Summary
Medical Affairs Excellence Services SummaryMedical Affairs Excellence Services Summary
Medical Affairs Excellence Services Summary
 
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
 
Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5
 
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
 
AMCP Keynote Presentation from Avella Specialty Pharmacy
AMCP Keynote Presentation from Avella Specialty PharmacyAMCP Keynote Presentation from Avella Specialty Pharmacy
AMCP Keynote Presentation from Avella Specialty Pharmacy
 
IMS Health Clinical Trial Optimization Solutions
IMS Health Clinical Trial Optimization SolutionsIMS Health Clinical Trial Optimization Solutions
IMS Health Clinical Trial Optimization Solutions
 
Benchmarking surgical systems 2015-30: application of indicators from The Lan...
Benchmarking surgical systems 2015-30: application of indicators from The Lan...Benchmarking surgical systems 2015-30: application of indicators from The Lan...
Benchmarking surgical systems 2015-30: application of indicators from The Lan...
 
2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy
2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy
2014 Armada Presentation - Specialty Pharmacy at Retail Pharmacy
 
Presentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchPresentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and research
 
Trends in Medical Affairs
Trends in Medical AffairsTrends in Medical Affairs
Trends in Medical Affairs
 
Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7
 
Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
 
Avoca Investigative Site Survey Programs
Avoca Investigative Site Survey ProgramsAvoca Investigative Site Survey Programs
Avoca Investigative Site Survey Programs
 
Benchmarking Professional Medical Education Excellence Structures
Benchmarking Professional Medical Education Excellence StructuresBenchmarking Professional Medical Education Excellence Structures
Benchmarking Professional Medical Education Excellence Structures
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 

Similar to Advocacy Groups: Enhancing Relationships and Patient Recruitment

Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryMedical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryBest Practices
 
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
 
SM 185A Patient Advocacy
SM 185A Patient AdvocacySM 185A Patient Advocacy
SM 185A Patient AdvocacyBest Practices
 
Global issues 12.5.13
Global issues 12.5.13Global issues 12.5.13
Global issues 12.5.13dbrown2014
 
Consumer Preferences of Hospitals among Square, United, Apollo and Labaid
Consumer Preferences of Hospitals among Square, United, Apollo and LabaidConsumer Preferences of Hospitals among Square, United, Apollo and Labaid
Consumer Preferences of Hospitals among Square, United, Apollo and LabaidAsifulla Azad
 
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...Best Practices
 
The Patient-Centered Clinical Trial: A New Paradigm
The Patient-Centered Clinical Trial: A New ParadigmThe Patient-Centered Clinical Trial: A New Paradigm
The Patient-Centered Clinical Trial: A New ParadigmJohn Reites
 
NURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docx
NURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docxNURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docx
NURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docx4934bk
 
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...Best Practices
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...MedStatix, LLC
 
Analytics_Wealth of Infomation
Analytics_Wealth of InfomationAnalytics_Wealth of Infomation
Analytics_Wealth of InfomationHeather Fraser
 
Types Of Rating Methods For Proposals That The Government...
Types Of Rating Methods For Proposals That The Government...Types Of Rating Methods For Proposals That The Government...
Types Of Rating Methods For Proposals That The Government...Monica Rivera
 
Tricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study TypesTricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study TypesImperial CRS
 
Implementing SBARStudents NameInstitutional
Implementing SBARStudents NameInstitutionalImplementing SBARStudents NameInstitutional
Implementing SBARStudents NameInstitutionalMalikPinckney86
 
Analyzing the Impact of the External Healthcare Environment on an.docx
Analyzing the Impact of the External Healthcare Environment on an.docxAnalyzing the Impact of the External Healthcare Environment on an.docx
Analyzing the Impact of the External Healthcare Environment on an.docxwrite22
 
Advocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpointAdvocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpointIMSHealthRWES
 
Principles of surgical audit
Principles of surgical auditPrinciples of surgical audit
Principles of surgical auditMeeran Earfan
 
Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)
Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)
Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)Geof Baker
 

Similar to Advocacy Groups: Enhancing Relationships and Patient Recruitment (20)

Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryMedical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
 
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
 
SM 185A Patient Advocacy
SM 185A Patient AdvocacySM 185A Patient Advocacy
SM 185A Patient Advocacy
 
Global issues 12.5.13
Global issues 12.5.13Global issues 12.5.13
Global issues 12.5.13
 
Consumer Preferences of Hospitals among Square, United, Apollo and Labaid
Consumer Preferences of Hospitals among Square, United, Apollo and LabaidConsumer Preferences of Hospitals among Square, United, Apollo and Labaid
Consumer Preferences of Hospitals among Square, United, Apollo and Labaid
 
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...
 
The Patient-Centered Clinical Trial: A New Paradigm
The Patient-Centered Clinical Trial: A New ParadigmThe Patient-Centered Clinical Trial: A New Paradigm
The Patient-Centered Clinical Trial: A New Paradigm
 
NURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docx
NURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docxNURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docx
NURS HEALTHCARE SYSTEMS AND QUALITY OUTCOMES Discussion 11.docx
 
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
 
Analytics_Wealth of Infomation
Analytics_Wealth of InfomationAnalytics_Wealth of Infomation
Analytics_Wealth of Infomation
 
Acc_POV_Trinity_PRINT
Acc_POV_Trinity_PRINTAcc_POV_Trinity_PRINT
Acc_POV_Trinity_PRINT
 
Types Of Rating Methods For Proposals That The Government...
Types Of Rating Methods For Proposals That The Government...Types Of Rating Methods For Proposals That The Government...
Types Of Rating Methods For Proposals That The Government...
 
5944966.ppt
5944966.ppt5944966.ppt
5944966.ppt
 
Tricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study TypesTricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study Types
 
Implementing SBARStudents NameInstitutional
Implementing SBARStudents NameInstitutionalImplementing SBARStudents NameInstitutional
Implementing SBARStudents NameInstitutional
 
Analyzing the Impact of the External Healthcare Environment on an.docx
Analyzing the Impact of the External Healthcare Environment on an.docxAnalyzing the Impact of the External Healthcare Environment on an.docx
Analyzing the Impact of the External Healthcare Environment on an.docx
 
Advocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpointAdvocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpoint
 
Principles of surgical audit
Principles of surgical auditPrinciples of surgical audit
Principles of surgical audit
 
Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)
Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)
Finding the Right Care for the Right Price, Cost and Quality (Geof Baker)
 

More from Industry Standard Research

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Industry Standard Research
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensIndustry Standard Research
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresIndustry Standard Research
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)Industry Standard Research
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Industry Standard Research
 
Market Access: department models and structures
Market Access: department  models and structuresMarket Access: department  models and structures
Market Access: department models and structuresIndustry Standard Research
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsIndustry Standard Research
 
Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyIndustry Standard Research
 
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)Industry Standard Research
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline AnalysisIndustry Standard Research
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Industry Standard Research
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentIndustry Standard Research
 
What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?Industry Standard Research
 

More from Industry Standard Research (20)

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
 
Market Access: department models and structures
Market Access: department  models and structuresMarket Access: department  models and structures
Market Access: department models and structures
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development Trends
 
Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and Technology
 
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Orphan Drug 101
 
Infographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer ProfileInfographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer Profile
 
Infographic: CRO Capital Market
Infographic: CRO Capital MarketInfographic: CRO Capital Market
Infographic: CRO Capital Market
 
2014 Clinical Development Year in Review
2014 Clinical Development Year in Review2014 Clinical Development Year in Review
2014 Clinical Development Year in Review
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
 
Bladder Cancer: profile and drug development
Bladder Cancer: profile and drug developmentBladder Cancer: profile and drug development
Bladder Cancer: profile and drug development
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...
 
[Infographic] Lung Cancer
[Infographic] Lung Cancer[Infographic] Lung Cancer
[Infographic] Lung Cancer
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
 
Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)  Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)
 
What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?
 

Recently uploaded

concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).kishan singh tomar
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Pregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfPregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfMedicoseAcademics
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 

Recently uploaded (20)

concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Cone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptxCone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptx
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Pregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfPregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdf
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 

Advocacy Groups: Enhancing Relationships and Patient Recruitment

  • 1. Advocacy Groups: Enhancing Relationships and Patient Recruitment Info@ISRreports.com ©2013 Industry Standard Research www.ISRreports.com PREVIEW
  • 2. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 2 act with confidence Report Overview This report provides qualitative insight on advocacy groups’ relationships with the pharmaceutical industry. The report explores their current philosophies toward clinical trials, provides recommendations and best practices for encouraging patient participation in trials, and identifies opportunities to partner (or build on existing partnerships) with the industry. What you will learn in this report • The type of relationships advocacy groups desire with industry, including: involvement in clinical trial design, collaboration on patient recruitment, and role in connecting patients to industry • Advocacy groups’ concerns with encouraging clinical trials, including: the need to remain neutral, patient education, and trial burden on patients • Recommendations and best practices for delivering messages to patients and families about clinical trials How you can use this report: • Uncover proven strategies to more effectively enroll patients in your rare disease/difficult-to- recruit trials • Learn to optimize communication strategies to ensure an “all inclusive” approach to relationship management considers all key players (advocacy groups, patients, caregivers, and investigators) • Develop strategies to anticipate, discuss, and mitigate advocacy group concerns and hesitations 1. Relationships with Pharma • Clinical Trial Design • Patient-Industry Relationship • Opportunities for Industry in Trial Design Process 2. Clinical Trial Focus • Clinical Trial Focus Spectrum • Concerns with Encouraging Clinical Trials • Website Focus on Clinical Trials 3. Clinical Trial Recruitment Practices • Clinical Trials 101 – Back to the Basics • Patient Registry • Recruitment Best Practices • Managing Relationships 4. Patient Advocacy Groups’ Requests of Pharma • Low Trial Focus Advocacy Groups • High Trial Focus Advocacy Groups 5. Patient Advocacy Group Profiles Major Sections
  • 3. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 3 act with confidence Methodology In ISR’s qualitative analysis, ISR conducted 40-minute telephone interviews with senior decision-makers at 10 US-based patient advocacy groups. The individuals interviewed hold a variety of roles within their organizations, but all are in a position to speak to their organization’s philosophy on clinical trials, as well as their organization’s broader relationships with the pharmaceutical industry.
  • 4. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 4 act with confidence Table of Contents Full table of contents and additional sample pages available in the full preview, free on our website: http://www.isrreports.com/product/advocacy-groups-enhancing-relation- ships-and-patient-recruitment/
  • 5. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 5 act with confidence www.isrreports.com  ©2013|  EDC-­‐ePRO  Market  Trends  and  Service  Provider  Performance                26   5%   5%   4%   5%   6%   20%   14%   11%   6%   11%   50%   43%   39%   40%   31%   25%   38%   46%   49%   52%   0%   20%   40%   60%   80%   100%   Integra[on  capabili[es  with  other   applica[ons  (ePRO,  IVR)   Technical  support  from  the  vendor   The  process  for  dealing  with  queries   Speed  of  the  applica[ons,  how  fast  the   pages  load   Human-­‐machine  interface  (how  intui[ve   the  soeware  is  to  operate)   No  impact   Slight  impact   Moderate  impact   High  impact   EDC Operational Improvements Most impactful EDC product attributes for trial success “For each of the EDC product attributes below, please indicate how much impact each has on your ability to successfully run a clinical trial that uses an EDC application.” (Base  =  100)   Of  the  list  of  attributes  provided,  respondents  indicate  that  “technical  support”  and  “integration   capabilities”  had  less  of  an  impact  on  running  clinical  trial  when  compared  to  the  software   performance.   © 2013 Industry Standard Research Sample Page Introduction As ISR’s research has revealed time and again, patient recruitment is one of the most difficult and time-consuming aspects of conducting a clinical trial. Though the biopharmaceutical industry utilizes a wide range of recruiting techniques, one that ISR believes has not been fully (or even adequately) leveraged is partnering with patient advocacy groups to encourage trial participation. Patient advocacy groups are spread across the spectrum regarding how involved they are with clinical trial recruitment. All respondents posit that clinical trials are the way to move forward but many have yet to delve into playing a role in the recruitment process. There are various reasons why an organization may not have fully developed this offering so industry will have to tailor its approaches to individual advocacy organizations. The bright side is that advocacy groups already playing in this space are searching for continued and more involved partnering opportunities and organizations without processes in place for patient education and recruitment are open to discussing partnering options with industry. This report sheds light on advocacy groups’ relationships with pharma, current philosophies toward clinical trials, best practices for encouraging patient participation in trials, and opportunities to partner (or build on existing partnerships) with pharma.
  • 6. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 6 act with confidence Sample Page Clinical Trial Recruiting Practices act with confidence www.ISRreports.com ©2013 | Advocacy Groups: Enhancing Relationships and Patient Recruitment 24 Best Practices Advocacy organizations have developed some best practices and some unique ideas for clinical trial education and recruitment� These practices will be detailed here as organizations can learn from successful strategies of other advocacy groups and industry can learn where it can lend a hand to support these initiatives� Delivery is Key Respondents shared several best practices in terms of delivering messages to patients and families about clinical trials� Consistent Language Consistency in language is critical� When messaging about key facts about a clinical trial, try to use the same wording as is used in other information about the trial from the sponsor company or CRO� This will help the patient to form a coherent understanding� Talk to PIs to understand how they talk about the trial with patients so a consistent message can be relayed to the patient community� Repetition Repeat� Repeat� Repeat� The messages of education and encouragement to participate in clinical trials have to be reinforced� One mention in a magazine article is not going to get the job done� Patients need to be educated on what trials are and need to be reminded about what trials are available� The National Multiple Sclerosis Society, for example, has found that interest is generated when a news bulletin about a study is first posted on its home page� If requested, the Society may or may not repost a trial on the home page every few months to garner renewed interest� Consistent Language Repetition Audience Understanding Impactful Message ©industry standard Research This is an enterprise-wide license and this file is not to be distributed beyond the terms of this agreement. For information on the license holder, please contact ISR (info@ISRreports.com).
  • 7. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 7 act with confidence Sample Page Full table of contents and additional sample pages available in the full preview, free on our website: http://www.isrreports.com/product/advocacy-groups-enhancing-relation- ships-and-patient-recruitment/
  • 8. www.ISRreports.com ©2013 | Preview of: Advocacy Groups: Enhancing Relationships and Patient Recruitment 8 act with confidence Ordering Information Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience in the industry, ISR delivers an un- matched level of domain expertise.    For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports. About Industry Standard Research Pricing and ordering options are available on our website: http://www.isrreports.com/product/advocacy-groups-enhancing-relation- ships-and-patient-recruitment/